Morningstar Investor users sign in here.

Company Profile

  • Business description

    3D Medicines Inc is a commercial-stage biopharmaceutical company that researches, develops, and commercialization drugs in the field of managing cancer as a chronic disease. It develops differentiated immuno-oncology drugs, helping cancer patients live with prolonged survival time and quality of life. It generates all of its revenue from China.

  • Contact

    No. 3 and No. 5, Laiyang Road
    Shandong
    Qingdao
    CHN

    https://www.3d-medicines.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2024

    Employees

    198

Stocks News & Analysis

stocks

2 ASX shares to avoid after results

These shares are trading at levels that are materially overvalued.
stocks

Strong results from IPO bolter not enough to change our view

Guzman's business has made an impressive start to the new fiscal year. We still have our doubts on valuation levels.
stocks

No sign of AI slowdown for Nvidia

Morningstar maintains our fair value estimate after latest earnings.

Markets

Index
Last price
Change
% Change
All Ordinaries 8,316.70 53.10 0.64%
CAC 40 7,630.95 10.00 -0.13%
DAX 40 18,906.92 5.65 -0.03%
Dow JONES (US) 41,563.08 228.03 0.55%
FTSE 100 8,376.63 3.01 -0.04%
HKSE 17,989.07 202.75 1.14%
NASDAQ 17,713.62 197.19 1.13%
Nikkei 225 38,647.75 285.22 0.74%
NZX 50 Index 12,447.68 94.07 0.76%
S&P 500 5,648.40 56.44 1.01%
S&P/ASX 200 8,091.90 46.80 0.58%
SSE Composite Index 2,842.21 19.11 0.68%

Market Movers

Name
Last price
Change
% Change
Aurizon Holdings Ltd AZJ 3.38 0.00 0.00%
Latin Resources Ltd LRS 0.20 0.01 -2.44%
Red 5 Ltd RED 0.34 0.02 6.25%
Droneshield Ltd DRO 1.33 0.09 7.29%
Mesoblast Ltd MSB 1.03 0.08 8.42%
Spartan Resources Ltd SPR 1.46 0.16 12.36%
Telstra Group Ltd TLS 3.93 0.02 0.51%
Pilbara Minerals Ltd PLS 2.97 0.06 2.06%
Appen Ltd APX 1.00 0.22 -17.70%
South32 Ltd S32 3.14 0.04 1.29%